Table 3.
Prevalence (standard errors [SEs]) of other lifetime DSM-5 psychiatric disorders by a history of suicidal attempts (SA) among individuals with lifetime diagnosis of anorexia nervosa (total and subtypes), bulimia nervosa, or binge-eating disorder
| AN | AN-R | AN-BP | BN | BED | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| SA Yes (n = 60) |
SA No (n = 216) |
SA Yes (n = 28) |
SA No (n = 162) |
SA Yes (n = 32) |
SA No (n = 54) |
SA Yes (n = 63) |
SA No (n = 29) |
SA Yes (n = 64) |
SA No (n = 254) |
|
| Any mood disorders | 86.4 (5.37) | 43.5 (2.82) | 81.7 (7.52) | 38.7 (3.32) | 89.9 (7.09) | 58.6 (5.55) | 96.0 (2.96) | 72.0 (4.57) | 88.1 (3.01) | 64.9 (3.09) |
| Major depressive disorder | 83.1 (5.98) | 38.4 (3.06) | 74.1 (9.04) | 36.0 (3.19) | 89.9 (7.09) | 46.0 (6.48) | 96.0 (2.96) | 67.3 (4.75) | 88.1 (3.01) | 59.3 (3.14) |
| Persistent depression | 46.9 (7.85) | 14.2 (2.05) | 50.2 (8.39) | 12.2 (1.89) | 44.4 (9.10) | 20.7 (3.05) | 56.5 (9.29) | 24.8 (6.18) | 53.7 (6.85) | 27.0 (3.05) |
| Bipolar I | 21.3 (6.75) | 3.7 (1.68) | 19. (7.90) | 2.8 (0.98) | 22.8 (6.83) | 6.5 (0.84) | 32.1 (11.11) | 4.3 (0.37) | 24.9 (6.08) | 4.2 (1.52) |
| Any anxiety disorders | 58.8 (8.04) | 34.4 (2.85) | 45.1 (8.81) | 33.5 (2.35) | 69.1 (9.45) | 37.3 (5.52) | 60.5 (11.17) | 37.3 (5.85) | 76.1 (5.21) | 54.2 (3.29) |
| Panic disorder | 36.3 (7.73) | 16.0 (2.47) | 23.1 (8.61) | 14.0 (1.69) | 46.1 (9.75) | 22.0 (3.33) | 32.2 (11.09) | 11.2 (2.52) | 45.7 (5.83) | 16.1 (2.16) |
| Agoraphobia | 17.7 (7.74) | 8.6 (2.32) | 9.3 (7.21) | 5.6 (1.80) | 23.9 (11.27) | 18.0 (3.85) | 13.6 (2.46) | 8.0 (2.27) | 23.6 (4.78) | 10.6 (1.92) |
| Social anxiety disorder | 18.1 (5.57) | 5.6 (1.35) | 14.6 (7.39) | 4.8 (1.07) | 20.6 (3.80) | 8.0 (3.80) | 22.8 (6.77) | 10.1 (2.18) | 30.7 (5.53) | 17.8 (3.00) |
| Specific phobia | 24.7 (7.74) | 12.2 (2.38) | 13.7 (4.82) | 12.2 (2.20) | 32.9 (10.25) | 12.3 (3.02) | 20.8 (7.19) | 11.5 (3.65) | 20.5 (5.06) | 25.5 (2.89) |
| General anxiety disorder | 31.8 (7.95) | 18.7 (2.39) | 22.1 (7.55) | 17.3 (1.52) | 39.1 (10.74) | 23.1 (4.52) | 27.9 (9.82) | 24.9 (5.63) | 41.1 (6.29) | 30.7 (2.69) |
| Posttraumatic stress disorder | 49.5 (7.91) | 13.8 (2.79) | 37.0 (8.90) | 11.3 (2.86) | 58.9 (8.49) | 21.5 (4.15) | 57.1 (13.19) | 21.2 (2.63) | 58.4 (7.31) | 24.1 (2.41) |
| Any substance use disorder | 82.9 (4.80) | 52.8 (3.45) | 91.2 (4.58) | 45.4 (4.27) | 76.7 (5.84) | 76.1 (4.71) | 82.1 (3.74) | 60.0 (5.92) | 75.9 (6.04) | 65.4 (3.08) |
| Alcohol use disorder | 72.8 (5.90) | 41.4 (2.76) | 71.0 (8.77) | 34.2 (3.23) | 74.2 (6.40) | 64.1 (5.81) | 79.9 (4.85) | 52.3 (5.79) | 61.3 (6.08) | 49.4 (3.29) |
| Nicotine use disorder | 59.1 (9.01) | 31.7 (3.79) | 77.4 (8.40) | 26.4 (4.44) | 45.5 (8.93) | 48.2 (6.89) | 68.5 (9.97) | 30.7 (3.23) | 50.9 (5.87) | 37.3 (3.42) |
| Other drug use disorder | 37.1 (6.74) | 11.2 (1.89) | 39.8 (9.45) | 6.5 (2.00) | 35.1 (7.16) | 25.9 (4.32) | 45.2 (10.92) | 22.4 (4.25) | 39.0 (6.61) | 20.8 (2.30) |
| Any personality or conduct disorder | 73.3 (8.47) | 22.5 (2.76) | 57.3 (8.19) | 16.9 (2.60) | 85.2 (5.78) | 40.4 (5.42) | 78.7 (14.13) | 38.4 (3.90) | 81.5 (4.83) | 48.9 (3.48) |
| Antisocial | 18.6 (5.61) | 5.5 (1.81) | 16.4 (6.74) | 2.2 (0.97) | 20.1 (4.85) | 15.9 (3.63) | 22.5 (7.17) | 5.2 (1.89) | 30.7 (5.65) | 11.7 (2.10) |
| Borderline | 62.1 (8.86) | 19.7 (2.79) | 48.6 (8.50) | 13.8 (2.44) | 72.2 (8.94) | 38.4 (5.45) | 77.2 (14.01) | 34.6 (4.06) | 77.6 (4.90) | 41.3 (3.77) |
| Schizotypal | 40.7 (7.71) | 9.1 (2.04) | 24.7 (8.24) | 5.2 (1.19) | 52.6 (9.62) | 21.1 (4.35) | 40.3 (9.61) | 17.4 (3.23) | 36.9 (5.70) | 25.3 (3.05) |
| Conduct | 24.3 (6.26) | 5.7 (1.82) | 29.9 (9.35) | 2.5 (1.02) | 20.1 (4.85) | 15.9 (3.63) | 22.5 (7.17) | 8.7 (1.99) | 30.7 (5.65) | 12.0 (2.12) |
Notes. AN anorexia nervosa, AN-R anorexia nervosa restricting subtype, AN-BP anorexia nervosa binge/purging subtype, BN bulimia nervosa, BED binge eating disorder. ED groups are not mutually exclusive as respondents may have had multiple lifetime ED diagnosis. All analyses adjusted for complex survey design of NESARC-III